SCHEMBL1959313

SCHEMBL1959313

COC(=O)c1cc(O)c2ccccc2c1-c1cc(Cl)cc(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
TSHR P16473 1/20 0.46
KDM4E B2RXH2 3/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
MAPT P10636 2/20 0.45
CNR2 P34972 2/20 0.44
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 2/20 0.43
NSD2 O96028 1/20 0.43
MCL1 Q07820 1/20 0.43
PDK2 Q15119 2/20 0.42
CNR1 P21554 1/20 0.42
GAA P10253 1/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170807 0.87 LMNA (0.50) LMNATSHRKDM4EKMT2AMEN1
SCHEMBL9898507 0.84 NR4A2 (0.50) LMNATSHRKDM4ESLC6A3KMT2A
SCHEMBL1711290 0.80 DHODH (0.56) LMNATSHRKDM4EKMT2AMEN1
SCHEMBL12424592 0.77 TSHR (0.46) LMNATSHRKDM4ESLC6A4SLC6A3
SCHEMBL1791233 0.77 KDM4E (0.66) LMNATSHRKDM4EKMT2AMEN1
SCHEMBL6171157 0.77 PLA2G2A (0.49) LMNATSHRKDM4EKMT2AMEN1
SCHEMBL12424591 0.76 EGFR (0.47) LMNATSHRKDM4ESLC6A4SLC6A3
SCHEMBL2470133 0.75 LMNA (0.55) LMNATSHRKDM4EKMT2AMEN1
SCHEMBL28283410 0.74 LMNA (0.53) LMNATSHRKDM4EKMT2AMEN1
SCHEMBL30128969 0.73 DHODH (0.46) LMNATSHRKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107253943-B Photochromic compounds and compositions 光学转变公司 2022-05-17 CN disclosed
EP-2651912-B1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL INC (US) 2018-10-03 EP disclosed
CN-107253943-A Photochromic compound and composition 光学转变公司 2017-10-17 CN disclosed
EP-2651913-B1 INDENO-FUSED RING COMPOUNDS HAVING PHOTOCHROMIC PROPERTIES TRANSITIONS OPTICAL INC (US) 2017-04-19 EP disclosed
US-9309455-B2 Indeno-fused ring compounds TRANSITIONS OPTICAL, INC. (US) 2016-04-12 US disclosed
US-9034219-B2 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2015-05-19 US disclosed
US-20140166948-A1 INDENO-FUSED RING COMPOUNDS TRANSITIONS OPTICAL LIMITED (IE) 2014-06-19 US disclosed
US-8698117-B2 Indeno-fused ring compounds TRANSITIONS OPTICAL, INC. (US) 2014-04-15 US disclosed
EP-2651913-A1 INDENO- FUSED RING COMPOUNDS HAVING PHOTOCHROMIC PROPERTIES Transitions Optical, Inc. (US) 2013-10-23 EP disclosed
EP-2651912-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS Transitions Optical, Inc. (US) 2013-10-23 EP disclosed
CN-103354810-A Photochromic compounds and compositions TRANSITIONS OPTICAL INC 2013-10-16 CN disclosed
WO-2013032608-A1 INDENO-FUSED RING COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2013-03-07 WO disclosed
US-20120156521-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 US disclosed
WO-2012082506-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 WO disclosed
WO-2012082381-A1 INDENO- FUSED RING COMPOUNDS HAVING PHOTOCHROMIC PROPERTIES TRANSITIONS OPTICAL, INC. (US) 2012-06-21 WO disclosed
US-20120126185-A1 INDENO-FUSED RING COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2012-05-24 US disclosed
US-20110140056-A1 Indeno-fused ring compounds TRANSITIONS OPTICAL, INC. (US) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120156521-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS CRY2, CRY1, PPOX LMNA 657/4885TSHR 4783/4885KDM4E 2937/4885
US-20110140056-A1 Indeno-fused ring compounds CRY2, SQOR, INTS6 LMNA 1680/4885TSHR 3550/4885KDM4E 464/4885
US-20120126185-A1 INDENO-FUSED RING COMPOUNDS CRY2, SQOR, INTS6 LMNA 1680/4885TSHR 3550/4885KDM4E 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.